10-K/AThe Record
Taysha Gene Therapies, Inc. files 10-K/A
Filed Apr 27, 2023 · 3y ago · Accession 0001193125-23-122086
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- 10-K/A
- Filing date
- Apr 27, 2023
- Report date
- Dec 31, 2022
- Document
- d488784d10ka.htm
- Size
- 551 KB